PVH
28
-2
BEN
55
-2
MUR
34
-2
FSLR
72
-6
CCL
89
-3
ADT
46
-4
RL
66
-3
MCHP
51
-7
XEL
43
2
WY
54
-2
IFF
57
-2
ETN
59
2
PAYX
39
-2
SWK
59
-2
OKE
67
2
TRIP
50
-2
PEG
46
-4
T
26
3
VTR
67
-2
GOOGL
50
2
PVH
28
-2
BEN
55
-2
MUR
34
-2
FSLR
72
-6
CCL
89
-3
ADT
46
-4
RL
66
-3
MCHP
51
-7
XEL
43
2
WY
54
-2
IFF
57
-2
ETN
59
2
PAYX
39
-2
SWK
59
-2
OKE
67
2
TRIP
50
-2
PEG
46
-4
T
26
3
VTR
67
-2
GOOGL
50
2
Financhill
Back

The New York Times Co. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
85

NYT
The New York Times Co.

Last Price:
$71.13
Seasonality Move:
5.79%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.34
Seasonality Move:
-34.19%
Buy
85
The New York Times Co. (NYT) is a Buy

Is The New York Times Co. a Buy, Sell or Hold?

  • The current The New York Times Co. [NYT] share price is $70.71. The Score for NYT is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
  • NYT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NYT Stock Price Chart

What is The New York Times Co.'s stock price today?

  • The The New York Times Co. share price today is $70.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing slight buying pressure.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

NYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.27 Buy
Relative Strength Index (14 RSI): 79.25 Buy
Chaikin Money Flow: 191188 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.77 - 68.75) Buy
Bollinger Bands (100): (55.99 - 64.43) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

NYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69.37 Buy
20-day SMA: 66.86 Buy
50-day SMA: 62.4 Buy
200-day SMA: 56.43 Buy
8-day EMA: 69.46 Buy
20-day EMA: 67.26 Buy
50-day EMA: 63.81 Buy
200-day EMA: 57.95 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

The New York Times Co. Earnings Growth & NYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.25 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

The New York Times Co. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):